ASO Visual Abstract: Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma - A Systematic Review and Meta-analysis

Jessica J. Holster; Marouan El Hassnaoui; Stijn Franssen; Jan N. M. IJzermans; Jeroen de Jonge; Bianca Mostert; Wojciech G. Polak; Roeland F. de Wilde; Marjolein Y. Homs; Bas Groot Koerkamp

doi:10.1245/s10434-022-11536-x

ASO Visual Abstract: Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma - A Systematic Review and Meta-analysis

Jessica J. Holster, Marouan El Hassnaoui, Stijn Franssen, Jan N. M. IJzermans, Jeroen de Jonge, Bianca Mostert, Wojciech G. Polak, Roeland F. de Wilde, Marjolein Y. Homs, Bas Groot Koerkamp^*

^*Corresponding author for this work

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

Abstract

Hepatic arterial infusion pump (HAIP) chemotherapy
with floxuridine has been explored as a means to control cancer
in the liver. In this systematic review (https://doi.org/10.1245/
s10434-022-11439-x), 478 patients with unresectable intrahepatic cholangiocarcinoma (iCCA) were identified from nine
studies; survival outcomes of 154 patients were used in the
meta-analysis. HAIP chemotherapy with floxuridine for
patients with unresectable iCCA was associated with a pooled
3-year overall survival (OS) of 39.5% (95% confidence interval
(CI) 31.5–47.4%) and a weighted median OS of 29.0 months
(range 25.0–39 months).

Original language	English
Pages (from-to)	5541-5542
Number of pages	2
Journal	Annals of Surgical Oncology
Volume	29
Issue number	9
Early online date	Mar 2022
DOIs	https://doi.org/10.1245/s10434-022-11536-x
Publication status	Published - Sept 2022

Bibliographical note

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1245/s10434-022-11536-x

Cite this

Holster, J. J., El Hassnaoui, M., Franssen, S., IJzermans, J. N. M., de Jonge, J., Mostert, B., Polak, W. G., de Wilde, R. F., Homs, M. Y., & Koerkamp, B. G. (2022). ASO Visual Abstract: Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma - A Systematic Review and Meta-analysis. Annals of Surgical Oncology, 29(9), 5541-5542. https://doi.org/10.1245/s10434-022-11536-x

@article{0e018efa564d45209ab1cb98b4e0ed24,

title = "ASO Visual Abstract: Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma - A Systematic Review and Meta-analysis",

abstract = "Hepatic arterial infusion pump (HAIP) chemotherapywith floxuridine has been explored as a means to control cancerin the liver. In this systematic review (https://doi.org/10.1245/s10434-022-11439-x), 478 patients with unresectable intrahepatic cholangiocarcinoma (iCCA) were identified from ninestudies; survival outcomes of 154 patients were used in themeta-analysis. HAIP chemotherapy with floxuridine forpatients with unresectable iCCA was associated with a pooled3-year overall survival (OS) of 39.5% (95% confidence interval(CI) 31.5–47.4%) and a weighted median OS of 29.0 months(range 25.0–39 months).",

author = "Holster, {Jessica J.} and {El Hassnaoui}, Marouan and Stijn Franssen and IJzermans, {Jan N. M.} and {de Jonge}, Jeroen and Bianca Mostert and Polak, {Wojciech G.} and {de Wilde}, {Roeland F.} and Homs, {Marjolein Y.} and Koerkamp, {Bas Groot}",

note = "{\textcopyright} Society of Surgical Oncology 2022",

year = "2022",

month = sep,

doi = "10.1245/s10434-022-11536-x",

language = "English",

volume = "29",

pages = "5541--5542",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer Science+Business Media",

number = "9",

}

Holster, JJ, El Hassnaoui, M, Franssen, S , IJzermans, JNM , de Jonge, J , Mostert, B , Polak, WG , de Wilde, RF , Homs, MY & Koerkamp, BG 2022, 'ASO Visual Abstract: Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma - A Systematic Review and Meta-analysis', Annals of Surgical Oncology, vol. 29, no. 9, pp. 5541-5542. https://doi.org/10.1245/s10434-022-11536-x

ASO Visual Abstract: Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma - A Systematic Review and Meta-analysis. / Holster, Jessica J.; El Hassnaoui, Marouan; Franssen, Stijn et al.
In: Annals of Surgical Oncology, Vol. 29, No. 9, 09.2022, p. 5541-5542.

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

TY - JOUR

T1 - ASO Visual Abstract: Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma - A Systematic Review and Meta-analysis

AU - Holster, Jessica J.

AU - El Hassnaoui, Marouan

AU - Franssen, Stijn

AU - IJzermans, Jan N. M.

AU - de Jonge, Jeroen

AU - Mostert, Bianca

AU - Polak, Wojciech G.

AU - de Wilde, Roeland F.

AU - Homs, Marjolein Y.

AU - Koerkamp, Bas Groot

PY - 2022/9

Y1 - 2022/9

N2 - Hepatic arterial infusion pump (HAIP) chemotherapywith floxuridine has been explored as a means to control cancerin the liver. In this systematic review (https://doi.org/10.1245/s10434-022-11439-x), 478 patients with unresectable intrahepatic cholangiocarcinoma (iCCA) were identified from ninestudies; survival outcomes of 154 patients were used in themeta-analysis. HAIP chemotherapy with floxuridine forpatients with unresectable iCCA was associated with a pooled3-year overall survival (OS) of 39.5% (95% confidence interval(CI) 31.5–47.4%) and a weighted median OS of 29.0 months(range 25.0–39 months).

AB - Hepatic arterial infusion pump (HAIP) chemotherapywith floxuridine has been explored as a means to control cancerin the liver. In this systematic review (https://doi.org/10.1245/s10434-022-11439-x), 478 patients with unresectable intrahepatic cholangiocarcinoma (iCCA) were identified from ninestudies; survival outcomes of 154 patients were used in themeta-analysis. HAIP chemotherapy with floxuridine forpatients with unresectable iCCA was associated with a pooled3-year overall survival (OS) of 39.5% (95% confidence interval(CI) 31.5–47.4%) and a weighted median OS of 29.0 months(range 25.0–39 months).

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:000768614500005&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1245/s10434-022-11536-x

DO - 10.1245/s10434-022-11536-x

M3 - Meeting Abstract

C2 - 35288815

SN - 1068-9265

VL - 29

SP - 5541

EP - 5542

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

IS - 9

ER -

ASO Visual Abstract: Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma - A Systematic Review and Meta-analysis

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this